Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.8 USD | -0.31% | +1.43% | +18.16% |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
05-01 | Redburn Atlantic Adjusts Price Target on Merck to $148 From $142 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.16% | 326B | |
+33.25% | 699B | |
+24.85% | 571B | |
-3.55% | 364B | |
+4.36% | 286B | |
+15.08% | 236B | |
+5.16% | 198B | |
-9.98% | 194B | |
-3.69% | 149B | |
-5.59% | 154B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co, OPKO Health's ModeX to Collaborate on Epstein-Barr Virus Vaccine Candidate